These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5717379)

  • 1. [Behavior of ceruloplasmin activity in some liver diseases].
    Procaccia S; Civardi F; Tenconi L; Massari N; Samaja U
    Minerva Med; 1968 Dec; 59(97):5267-8. PubMed ID: 5717379
    [No Abstract]   [Full Text] [Related]  

  • 2. [Haptoglobin and ceruloplasmin in liver and biliary tract diseases].
    Prellwitz W; Hammar CH; Dudeck J
    Dtsch Med Wochenschr; 1968 Jun; 93(26):1277-81. PubMed ID: 5653473
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ceruloplasmin in chronic liver diseases].
    Mardare G; Strat C; Drăgan M; Terek C; Pandele G; Boingeanu A
    Med Interna (Bucur); 1973 Feb; 25(2):229-36. PubMed ID: 4793927
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiocopper (64Cu) incorporation into ceruloplasmin in chronic active hepatitis and in liver cirrhosis.
    Piaggi V; Zeneroli ML; Rocchi E; Gibertini P; Cremonini C; Gozzi MG; Ventura E
    J Nucl Med Allied Sci; 1980; 24(3-4):177-81. PubMed ID: 7252581
    [No Abstract]   [Full Text] [Related]  

  • 5. Conjugated and unconjugated serum bile acid levels n patients with hepatobiliary diseases.
    Makino I; Nakagawa S; Mashimo K
    Gastroenterology; 1969 Jun; 56(6):1033-9. PubMed ID: 5788911
    [No Abstract]   [Full Text] [Related]  

  • 6. Ceruloplasmin activity in liver diseases quantitative determination and electrophoretic characterization.
    Secchi GC; Petrella A; Lomanto B; Gervasini N
    Enzymol Biol Clin (Basel); 1967; 8(1):33-41. PubMed ID: 6030815
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasmatic angiotensinase activity in subjects with hepatic diseases of various types].
    Morandini G; Dimich D; Manca P; Spanedda M
    Minerva Med; 1967 May; 58(40):1876-81. PubMed ID: 4290743
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronic aggressive hepatitis].
    Creutzfeldt W
    Dtsch Med Wochenschr; 1973 Mar; 98(11):580-1. PubMed ID: 4695004
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new approach to the diagnosis of cholestasis by the activity of copper-containing enzymes].
    Loginov AS; Matiushin BN; Tkachev VD; Iakimchuk GN
    Ter Arkh; 1993; 65(2):34-6. PubMed ID: 9133006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guanase activity of human blood in viral hepatitis and other liver diseases].
    Giusti G; Galanti B
    Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1567-8. PubMed ID: 5878188
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnostic value of determining ceruloplasmin and transferrin in various acute and chronic liver diseases].
    Dzhalalov AD; Maksimov VA
    Ter Arkh; 1982; 54(2):57-9. PubMed ID: 7071774
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemostasis and liver disease.
    Mannucci PM; Mari D
    Haematologica; 1981 Apr; 66(2):233-48. PubMed ID: 6792002
    [No Abstract]   [Full Text] [Related]  

  • 13. Antifibrinolysin effect of thrombocytes.
    Schulz K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(3):263-71. PubMed ID: 4106018
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significance of the uranyl acetate test in the diagnosis of liver diseases].
    Fischer P; Reinelt D
    Z Gesamte Inn Med; 1968 Jun; 23(12):Suppl:177-9. PubMed ID: 5687435
    [No Abstract]   [Full Text] [Related]  

  • 15. Haptoglobin and caeruloplasmin in diseases of the liver and biliary tract.
    Prellwitz W; Hammar CH; Dudeck J
    Ger Med Mon; 1969 Jan; 14(1):23-7. PubMed ID: 5352740
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ceruloplasmin content during liver cirrhosis and anemia].
    Baronina MA; Zamchiĭ AA; Zherebtsov LA; Mikhaĭlova LI
    Probl Gematol Pereliv Krovi; 1971 Oct; 16(10):18-21. PubMed ID: 5125888
    [No Abstract]   [Full Text] [Related]  

  • 17. [A quick micromethod for the determination of esterized serum cholesterol].
    Walter H; Straube KH
    Dtsch Gesundheitsw; 1965 Dec; 20(48):2147-8. PubMed ID: 5873255
    [No Abstract]   [Full Text] [Related]  

  • 18. [Factor IX in liver diseases].
    Balkuv S; Oktay E; Ulutin ON; Barlas O
    Turk Tip Cemiy Mecm; 1967 Mar; 33(3):133-7. PubMed ID: 6039950
    [No Abstract]   [Full Text] [Related]  

  • 19. [Osmotic resistance of erythrocytes in hepato-biliary diseases].
    Ando T; Yoshida H; Terakura T; Fukazawa T; Takahashi Y
    Nihon Shokakibyo Gakkai Zasshi; 1977 Mar; 74(3):329-39. PubMed ID: 558411
    [No Abstract]   [Full Text] [Related]  

  • 20. Some clinical and experimental observations on serum peptidase activity in hepatic disorders.
    Horký J; Placer Z; Sousek O
    Clin Chim Acta; 1967 May; 16(2):279-85. PubMed ID: 6033519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.